Literature DB >> 12034091

Optimization of foot-and-mouth disease vaccination protocols by surveillance of neutralization antibodies.

W B Chung1, P C Liao, S P Chen, P C Yang, Y L Lin, M H Jong, T W Sheu.   

Abstract

An appropriate immunization program for pigs in a foot-and-mouth disease (FMD) endemic area was proposed based on data analysis obtained from serological surveillance in Taiwan, after an intensive vaccination program. To provide an adequate passive immunity for piglets, gilts that have completed two basic vaccinations must be boosted once before breeding. To achieve an efficient response to the FMD vaccine for piglets born to well vaccinated sows, vaccination need to be delayed until 10-12 weeks of ages for the first immunization, followed by a boost 4 weeks later.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12034091     DOI: 10.1016/s0264-410x(02)00201-3

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  4 in total

1.  Promising multiple-epitope recombinant vaccine against foot-and-mouth disease virus type O in swine.

Authors:  Jun-Jun Shao; Chung Kai Wong; Tong Lin; Shuk Kwan Lee; Guo-Zheng Cong; Fion Wai Yee Sin; Jun-Zheng Du; Shan-Dian Gao; Xiang-Tao Liu; Xue-Peng Cai; Yong Xie; Hui-Yun Chang; Ji-Xing Liu
Journal:  Clin Vaccine Immunol       Date:  2010-11-17

2.  Increased humoral antibody response of foot-and-mouth disease virus vaccine in growing pigs pre-treated with poly-γ-glutamic acid.

Authors:  Jee-Hoon Lee; Ik-Jae Kang; A-Reum Kim; You-Sun Noh; Hee-Chun Chung; Bong-Kyun Park
Journal:  J Vet Sci       Date:  2016-06-30       Impact factor: 1.672

Review 3.  Challenges of Generating and Maintaining Protective Vaccine-Induced Immune Responses for Foot-and-Mouth Disease Virus in Pigs.

Authors:  Nicholas A Lyons; Young S Lyoo; Donald P King; David J Paton
Journal:  Front Vet Sci       Date:  2016-11-30

Review 4.  Understanding the molecular epidemiology of foot-and-mouth-disease virus.

Authors:  Joern Klein
Journal:  Infect Genet Evol       Date:  2008-11-28       Impact factor: 3.342

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.